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Abstract 
BACKGROUND: The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing globally. Early 
identification of liver steatosis (LS) status is critical to prevent the development of NAFLD into non-alcoholic 
steatohepatitis (NASH) fibrosis.  
AIM: This study aimed at exploring the validity of simple anthropometric and biochemical parameters to predict LS 
in young obese women.  
MATERIALS AND METHODS: This is a cross-sectional study involving 132 young obese women. We collected 
the data of measured waist circumference (WC), body mass index (BMI), serum triglyceride (TG), and gamma-
glutamyltransferase (GGT). The lipid accumulation product (LAP) was designed from TG and WC variables. Fatty 
liver index (FLI) was calculated from TG, BMI, WC, and GGT variables. LS status was measured using 
ultrasonography assay. Statistical significance was set at p < 0.05. 
RESULTS: A positive correlation was found between BMI, WC, TG, GGT, LAP, FLI, and LS (p = 0.001). We 
found that BMI is a better predictor for LS to WC. Our multiple linear regression analysis revealed that BMI, 
GGT,and TG could predict 41.4% of LS. The validity (specificity, sensitivity, and odds ratio) of simple body fat 
parameters in predicting LS were as follows: BMI ≥ 30 kg/m
2
 (69.6%, 74.4%, and 6.21), WC ≥ 90 cm (67.4%, 
70.0%, and 4.28), TG ≥ 100 mg/dL (70.6%, 70.0%, and 5.62) and GGT ≥ 20 μg/L (69.6%, 77.5%, and 7.87), as 
well as LAP ≥ 30 (82.6%, 70.0%, and 11.1), and FLI ≥ 2.5 (79.3%, 72.5%, and 10.1), significantly. 
CONCLUSION: Simple anthropometric and biochemical parameters (BMI, WC, and TG, GGT), are appropriately 
predicting LS as well as LAP, and FLI among obese Balinese young women. 
 
 
 
 
 
 
Introduction 
 
Non-alcoholic fatty liver disease (NAFLD) is 
related to metabolic syndrome, while non-alcoholic 
steatohepatitis (NASH) can develop cirrhosis and liver 
failure. As the prevalence of NAFLD increases, it 
arises as a public health problem. It is predicted that 
within one decade the prevalence of NAFLD will be 
twice as much. In the western population, its 
prevalence ranges from 15 to 35%, with 10% of these 
will progress to NASH.  
The prevalence of NAFLD is 58% in 
overweight people and 98% in non-diabetic, obese 
population [1]. Within 10 years, NAFLD can progress 
from liver steatosis (LS) to NASH (47%), and to 
advanced NASH fibrosis and cirrhosis (20-50%) [2]. 
The prevalence of NAFLD in Asia is 15-30%, and this 
figure rises to 50% in those with metabolic syndrome 
[3] [4]. 
LS is initiated by the increased of visceral fat 
mass in an individual with obese. Measuring visceral 
fat mass is essential for identifying the risk to LS. 
While computer tomographic (CT) scan is still the gold 
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standard to measure visceral fat, some specific body 
fat parameters which include waist-to-height ratio 
(WtHR), conicity index (c-index), visceral adiposity 
index (VAI), and lipid accumulation product (LAP) can 
also be used to predict visceral fatness [5]. Bedogni et 
al., developed the fatty liver index (FLI), that is 
calculated from the waist circumference (WC), body 
mass index (BMI), gamma-glutamyltransferase 
(GGT), and serum triglyceride (TG) [6].  
A biopsy of the liver is the gold standard in 
diagnosing NAFLD, especially in NASH. However, 
other methods are available as a less invasive option, 
such as imaging. Ultrasonography (US) is one tool 
that is generally used for steatosis screening, despite 
its lack of sensitivity [7].
 
It is a cost-effective and well-
established as an imaging technique in diagnosing 
LS. Its downside is an operator-dependent diagnosis 
tool, rather qualitative than quantitative, and lacking 
accuracy in detecting mild hepatic steatosis [8]. 
In the early stage, NAFLD presents with 
asymptomatic LS which can progress further to 
NASH. However, in many countries, there is no 
regular screening program for detecting asymptomatic 
LS. Identification of early and asymptomatic LS is 
critical because of its progression to NASH, advanced 
fibrosis, and cirrhosis can be prevented. Simple body 
fat parameters and biochemical measurements could 
be used to predict asymptomatic LS, while the 
progression of asymptomatic LS to the late stage of 
NAFLD, NASH, advanced fibrosis, and cirrhosis can 
be achieved through managing lifestyle, body weight, 
diet, and exercise.  
 
 
Material and Methods 
 
This was a cross-sectional study involving 
132 young, obese (aged 18-25 years, BMI > 25 kg/m
2
) 
women in Bali, Indonesia. Data were collected from 
April to September 2013. A written informed consent 
was obtained before commencing the study, and the 
participants’ anonymity was maintained throughout. 
The study protocol was approved by the Committee of 
Ethical Research of Udayana University/Sanglah 
General Hospital. 
Anthropometric and biochemical variables 
were assessed. All anthropometric variables were 
measured twice, and for the final analyses mean 
values were used. Body weight (BW) was measured 
by a digital scale (Omron HBF-362, Japan) and 
presented in kilogram (kg). Body height (BH) was 
measured using a stature meter (General Care 26SM) 
and presented in centimetre (cm). WC was measured 
using a non-elastic, flexible tape at the middle level of 
the abdomen. Both TG and GGT were analysed by a 
colourimetric method (Cobas 6000, Roche 
Diagnostics, Germany). LAP for women was 
calculated as [WC (cm) −(5,9,10,11)  Finally, FLI was 
calculated as (e0.953* loge(TG) +0.139*(BMI) 
+0.718*loge(GGT) +0.053*WC -15.745)/ (1- e0.953* 
loge(TG) +0.139*(BMI) +0.718*loge(GGT) 
+0.053*(WC) -15.745) * 100. No adjustment of any 
kind was made in this study regarding any 
calculations of the anthropometry [5] [6] [9] [10] [11]. 
Liver steatosis (LS) was assessed using 
ultrasonography (US) imaging (Logiq 500, GE, 
Solingen, Germany), setting at 3-5 MH curve linear 
frequencies. The imaging was focused on the right 
subcostal-longitudinal and transversal axis line of the 
subject. The results were interpreted independently by 
three radiologists, and the final interpretation was 
concluded by the majority decision.  
LS criteria were described as: (1) normal liver, 
absence of steatosis and other liver disorder, (2) mild 
steatosis, marked by the appearance of liver 
parenchymal or hepatorenal echo contrast, a little bit 
brighter without disorder of intrahepatic vascular, (3) 
moderate steatosis, marked by liver parenchymal or 
hepatorenal appearance brighter in most area without 
intrahepatic vascular disorder, and (4) severe 
steatosis, marked by a diffuse and brighter liver 
appearance with blunting intrahepatic vascular [12] 
[13]. 
Statistical analyses were performed using 
Stata 12.1 (Stata Corp, College Station, TX, USA). 
The normal distribution of continuous data is 
presented as a mean ± standard error of the mean 
(SE). We employed a Pearson correlation test for 
continues data to assess the relationship between 
anthropometrical, biochemical, and LS, followed by 
multiple linear regression. One way ANOVA test was 
used to compare mean values of risk variables by the 
stage of LS. For ordinal variables, we employed non-
parametric analyses which include calculation of odds 
ratio (OR), specificity, and sensitivity value to predict 
liver steatosis. Statistical significance was set at p < 
0.05 (95% CI). 
 
 
Results 
 
This study enrolled 132 obese young women. 
Most of them were Balinese (94.7%), and a university 
student (90.9%). Table 1 depicts the demographic 
characteristics and descriptive data of the study 
participants. Average of BMI and WC were 30.4 ± 
0.43 kg/m
2
 and 90.4 ± 1.06 cm respectively. Most 
subjects (87.1%) had abdominal obesity (WC ≥ 80 
cm). Mean TG and GGT serum concentrations were 
104.6 ± 4.31 mg/dL and 24.4 ± 1.47 μg/L respectively, 
which were above the normal level. LS was found in 
30.3% subjects, varied from mild (13.6%), moderate 
(6.8%), and severe (9.8%). 
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Table 1: Characteristics description of subjects (n = 132) 
Parameters Mean ± SE N (%) 
Age (year) 20.7 ± 0.20  
Height (cm) 158.2 ± 0.74  
Weight (kg) 76.7 ± 2.00  
BMI (kg/m
2
) 30.4 ± 0.43  
25.0-29.9  70 (53.0) 
30.0-39.9  54 (40.9) 
≥ 40  8 (6.1) 
WC (cm) 90.4 ± 1.06  
< 80  17 (12.9) 
≥ 80  115 (87.1) 
   
TG (mg/dL) 104.6 ± 4.31  
GGT (μg/L) 24.4 ± 1.47  
Liver Steatosis  40 (30.3) 
Mild  18 (13.6) 
Moderate  9 (6.8) 
Severe  13 (9.8) 
Presented in mean ± SE (standard error of mean) for continous data; N(%) for catagorical 
data. BMI = body mass index, WC = waist circumference; TG = trygliceride, GGT = 
gamma-glutamyltransferase. 
 
Table 2 shows the association between all 
anthropometric variables, biochemical parameters, 
body fatness, and LS status. We found a strong 
positive correlation (p-value < 0.001) between 
anthropometric variables, biochemical parameters 
(TG, GGT), body fatness, and LS status.  
Table 2: Correlation matrix of body mass index (BMI), waist 
circumference (WC), Waist to Height Ratio (WHtR), Lipid 
accumulation product (LAP), fatty liver index (FLI), plasma 
Triglyceride (TG), plasma gamma-GT (GGT) and liver steatosis 
(LS) 
Parameters BMI  WC CI WHtR TG GGT  LAP FLI LS 
BMI 1         
WC 0.867* 1        
CI 0.462* 0.826* 1       
WHtR 0.854* 0.960* 0.823* 1      
TG 0.460* 0.467* 0.361* 0.494* 1     
GGT 0.470* 0.489* 0.319* 0.466* 0.379* 1    
LAP 0.746* 0.797* 0.624* 0.804* 0.861* 0.494* 1   
FLI 0.860* 0.787* 0.446* 0.756* 0.465* 0.529* 0.776* 1  
LS 0.588* 0.588* 0.417* 0.607* 0.449* 0.494* 0.592* 0.567* 1 
Presented in Pearson’s correlation coefficient. *p < 0.001. LS 1 = none, 2 = mild, 3 = 
moderate, 4 = severe. 
 
Our multiple linear regression suggested that 
BMI, GGT, and TG could predict 41.4% of liver 
steatosis, as shown in Table 3. We found a weak 
association between WC and LS in comparison to 
BMI, TG, and GGT. Therefore we removed the WC 
variable from the final model. 
Table 3: Regression of body mass index (BMI), plasma gamma-
glutamylTransferase (GGT), and triglyceride (TG) to liver 
steatosis 
Dependent Independents B SE  Beta p 
R 
square 
Liver 
Steatosis 
(Constant) -1.555 0.438   0.001  
0.414 BMI 0.080 0.017  0.395 < 0.001 
GGT 0.014 0.005  0.242 0.003 
TG 0.003 0.002  0.171 0.031 
 The variation of LS value determined by the model 41.4%. 
Analysed using linear regression, Independent variable enter; BMI, WC, TG and GGT. 
 
Table 4 depicts the relationship between 
predictor variables and LS status. We found a 
significant association between all predictor variables 
and LS status. We found a consistent increase of 
association based on the stages of LS.  
Table 4: Relationship of some determinants parameter to Liver 
Steatosis 
Determinant  
Liver Steatosis 
None 
(92) 
Mild 
(18) 
Moderate 
(9) 
Severe 
(13) 
p 
Body Mass 
Index (kg/m
2
) 
28.7 ± 0.33
*†‡
 32.0 ± 0.85
*§ 
32.4 ± 1.22
†ǁ
 
38.2 ± 
2.28
‡§ǁ
 
* 
0.002 
†
 0.009 
‡ 
< 0.001 
§ 
< 0.001 
ǁ
 0.001 
Waist 
Circumference 
(cm) 
86.4 ± 0.88
*†‡ 
94.3 ± 2.39
*§ 
95.0 ± 3.71
†ǁ
 
110 ± 
4.58
‡§ǁ
 
* 
0.002 
† 
0.014 
‡ 
< 0.001 
§ 
< 0.001 
ǁ 
< 0.001
 
Conicity Index 1.18 ± 0.008
*†‡
 1.22 ± 0.020
*§
 1.23 ± 0.034
†
 
1.29 ± 
0.022
‡§
 
* 
0.054 
† 
0.057 
‡ 
< 0.001 
§ 
0.013
 
Waist to Height 
Ratio 
0.545 ± 
0.005
*†‡
 
0.594 ± 
0.012
*§
 
0.606 ± 
0.025
†ǁ
 
0.686 ± 
0.026
‡§ǁ
 
* 
0.001 
†
 0.003 
‡ 
< 0.001 
§ 
< 0.001 
ǁ 
< 0.001
 
Triglyceride 
(mg/dL) 
89.7 ± 3.54
*†‡
 134 ± 12.3
*
 122 ± 21.2
†
 157 ± 20.0
‡
 
* 
< 0.001 
†
 0.037 
‡ 
< 0.001
 
Gamma-
Glutamyltransfer
ase (μg/L) 
19.5 ± 1.26
*‡
 30.8 ± 3.76
*§
 25.1 ± 4.80
ǁ
 
48.7 ± 
6.79
‡§ǁ
 
* 
0.003 
‡ 
< 0.001 
§ 
0.001 
ǁ 
< 0.001 
Lipid 
Accumulation 
Product 
29.6 ± 1.81
*†‡
 55.2 ± 5.81
*§
 53.1 ± 12.8
†ǁ
 
98.3 ± 
17.9
‡§ǁ
 
* 
0.001 
† 
0.017 
‡ 
< 0.001 
§ 
< 0.001 
ǁ 
< 0.001 
Fatty Liver 
Index 
1.88 ± 0.38
‡
 5.63 ± 1.51
§
 6.13 ± 3.08
ǁ
 
30.5 ± 
8.65
‡§ǁ
 
‡ 
< 0.001 
§ 
< 0.001 
ǁ 
< 0.001 
Presented in mean ± standard error of the mean (SE). Analysed using one-way ANOVA. 
The significance level (p-value) of; none vs mild steatosis*, none vs moderate steatosis
†
, 
none vs severe staetosis
‡
, mild vs severe steatosis
§
, and moderate vs severe steatosis
ǁ
. 
 
Simple anthropometric parameters (BMI, WC, 
CI, and WHtR), biochemical indexes (TG, GGT), and 
complex body fatness indicators could predict liver 
steatosis significantly (Table 5).  
Table 5: Specificity, Sensitivity and the OR to predict Liver 
Steatosis (US) of somebody fatness parameters 
Parameters 
(cut off) 
Specificity 
(None = 92) 
F (%) 
Sensitivity 
(Steatosis = 40) 
F (%) 
OR (95% CI) p 
BMI (≥ 30 kg/m
2
) 64 (69.6) 29 (74.4) 6.21 (2.66-14.5) < 0.001 
WC (≥ 90 cm) 62 (67.4) 28 (70.0) 4.82 (2.16-10.8) < 0.001 
CI (≥ 1.2) 59 (64.1) 29 (74.4) 4.53 (1.99-10.3) < 0.001 
WHtR (≥ 0.55) 58 (63.0) 31 (77.5) 6.34 (2.59-15.5) < 0.001 
TG (≥ 100 mg/dL) 65 (70.6) 28 (70.0) 5.62 (2.50-12.6) < 0.001 
GGT (≥ 20 μg/L) 64 (69.6) 31 (77.5) 7.87 (3.31-18.7) < 0.001 
LAP (≥ 30) 76 (82.6) 28 (70.0) 11.1 (4.67-26.3) < 0.001 
FLI (≥ 2.5) 73 (79.3) 29 (74.4) 10.1 (4.29-23.9) < 0.001 
BMI = body mass index, WC = waist circumference, CI = conicity index, WHtR = waist to 
height ratio, TG = triglyceride, GGT = gamma glutamyltransferase, LAP = lipid 
accumulation product, FLI = fatty liver index, OR = odd ratio. 
 
The validity indicators (specificity, sensitivity 
and the odds ratio (95%CI)) of body fat parameters 
which could predict LS were as follows: BMI ≥ 30 
kg/m
2
 (69.6%, 74.4% and 6.21(2.66-14.5)), WC ≥ 90 
cm (67.4%, 70.0% and 4.28(2.16-10.8)), CI ≥1.2 
(64.1%, 74.4%, and 4.53(1.99-10.3)), TG ≥ 100 mg/dL 
(70.6%, 70.0% and 5.62(2.50-12.6)), GGT ≥ 20 μg/L 
(69.6%, 77.5% and 7.87(3.31-18.7)), LAP ≥ 30 
(82.6%, 70.0% and 11.1(4.67-26.3)), and FLI ≥ 2.5 
(79.3%, 72.5% and 10.1(4.29-23.9)). 
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Discussion 
 
NAFLD has emerged into a serious problem 
worldwide. LS is an early stage of NAFLD that 
naturally will progress to NASH (47%), of which as 
many as 25-50% will eventually progress to cirrhosis 
or fibrosis. Following the next ten years, as many as 
7% will progress to hepatocellular carcinoma, 
contribute to 20% of liver-related death, and 50% will 
require a liver transplant [2].
 
It is important for 
healthcare providers to understand and identify this 
entity at an earlier stage and deliver the appropriate 
treatment.  
The objective of treating NAFLD is to prevent 
fibrosis and improve steatosis. Current treatment 
relies on treating existing related entities such as 
obesity and insulin resistance. Weight loss, achieved 
through the lifestyle and behavioural interventions 
such as diet and exercise, is still the main strategy to 
prevent the progression of NAFLD [14].
 
Our previously 
randomised clinical trial [15] [16] found that three 
months restriction energy intake with a supplement of 
low n6:n3 (2:1) polyunsaturated fatty acid (PUFA) 
ratio, and weekly moderate exercise, decreased body 
fat parameters, improved cytokines levels, controlled 
fasting blood glucose, and reduced LS. 
Body fatness, particularly visceral fat, is 
strongly associated with NAFLD. Oshakbayev et al., 
[17] reported NAFLD patients were found to have 
increased visceral fat rating, increased metabolic age 
by 9.6 years, and a basal metabolic rate of 209 
kcal/day. 
FLI, LAP, and VAI are body fatness indexes 
which can be used to predict cardiovascular, 
metabolic accurately, and liver-related diseases [6] [9] 
[10].
 
Both LAP and FLI can be utilised to recognise 
patients with hepatic steatosis [18].
 
FLI is a non-
invasive diagnostic tool that is known for its strong 
agreement to SteatoTest and moderate agreement to 
abdominal ultrasound or hepatorenal imaging [19].
 
Du 
et al., [20] reported that VAI and LAP are sensitive in 
recognising the metabolic obese-normal weight 
(MONW) phenotype among Chinese adults. 
Despite FLI’s ability in recognising NAFLD, a 
simpler visceral fat assessment like waist 
circumference was found to have a similar 
performance [21].
 
Rinella et al., [22] investigated that 
there was a proven correlation between the overall 
grade of steatosis and BMI in liver donors. A 
population-based study by Stranges et al., [23] found 
that abdominal height was related to GGT and ALT 
levels, with women showed a stronger correlation.  
Our study aims to identify predictors of 
NAFLD instead of defining the diagnosis of NAFLD. 
Understanding these predictors can guide the 
management of NAFLD especially in modifying risk 
factors associated with the development of NAFLD to 
NASH. Until recently, there is no definitive and 
specific pharmacologic regiment available for treating 
NAFLD. Simple anthropometric and biochemical 
predictors such as BMI, WC, TG, and GGT are readily 
available at all level of medical care services, 
especially at primary care. These predictors can be 
modified through behavioural interventions to prevent 
the progression of NAFLD to advanced NASH. Also, 
managing these predictors is also beneficial to reduce 
the risk for cardiovascular and metabolic-related 
diseases effectively. 
In conclusion, there is a significant 
relationship between liver steatosis with all body fat 
parameters. These phenomena indicate that the 
simple single anthropometric (BMI, WC) and also the 
biochemical (TG, GGT) parameters are appropriate as 
hallmarks for predicting liver steatosis as well as the 
complex fatness parameters (such as FLI and LAP) 
among the obese Balinese young women. 
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